ImmuCell Corporation Deferred State and Local Income Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Deferred State and Local Income Tax Expense (Benefit) of -$111.89 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation deferred state and local income tax expense (benefit) for fiscal 2025 was -$111.89K.
- ImmuCell Corporation deferred state and local income tax expense (benefit) for fiscal 2024 was -$59.03K, a 140.49% decline from fiscal 2023.
- ImmuCell Corporation deferred state and local income tax expense (benefit) for fiscal 2023 was $145.80K, a 64.69% increase from fiscal 2022.
- ImmuCell Corporation deferred state and local income tax expense (benefit) for fiscal 2022 was $88.53K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$111.89K 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$59.03K 10-K · filed 2026-03-30 | $59.03K 10-K · filed 2025-03-28 |
| 2023-12-31 | $145.80K 10-K · filed 2025-03-28 | |
| 2022-12-31 | $88.53K 10-K · filed 2024-04-01 | -$88.53K 10-K · filed 2023-03-29 |
| 2021-12-31 | -$14.99K 10-K · filed 2023-03-29 | $14.99K 10-K · filed 2022-03-30 |
| 2020-12-31 | $24.34K 10-K · filed 2022-03-30 | -$24.34K 10-K · filed 2021-03-30 |
| 2019-12-31 | -$31.20K 10-K · filed 2021-03-30 | |
| 2018-12-31 | -$504.07K 10-K · filed 2020-03-27 | |
| 2017-12-31 | -$111.63K 10-K · filed 2019-03-22 | |
| 2016-12-31 | -$16.37K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $205.43K 10-K · filed 2017-03-30 | |
| 2012-12-31 | $12.14K 10-K · filed 2013-03-28 | |
| 2011-12-31 | -$36.78K 10-K · filed 2013-03-28 | |
| 2010-12-31 | -$35.89K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |